Format

Send to

Choose Destination
Infect Control Hosp Epidemiol. 2002 Mar;23(3):155-8.

Antimicrobial use prior to the acquisition of multiresistant bacteria.

Author information

1
Department of Bacteriology, Hygiene and Infection Control, Hôpital Nord, Amiens, France.

Abstract

We assessed whether patients who acquired methicillin-resistant Staphylococcus aureus (MRSA) had less exposure to antimicrobial agents than did those who acquired Enterobacteriaceae that produced extended-spectrum beta-lactamase (ESbetaL). In a 6-month, prospective study, ESbetaL carriers had received antimicrobial therapy more often than had MRSA carriers. Amoxicillin-clavulanic acid, fluoroquinolones, and third-generation cephalosporins, especially ceftazidime, had been prescribed more often for ESbetaL carriers than for MRSA carriers.

PMID:
11918124
DOI:
10.1086/502029
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Cambridge University Press
Loading ...
Support Center